Page last updated: 2024-11-06

4-methylmorpholine n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methylmorpholine N-oxide (NMO) is a versatile oxidant widely used in organic synthesis. It is a colorless, crystalline solid that is soluble in water and most organic solvents. NMO is a mild and selective oxidant that is commonly employed for the oxidation of alcohols to aldehydes and ketones, the epoxidation of alkenes, and the oxidative cleavage of alkenes. NMO is typically synthesized by the oxidation of 4-methylmorpholine using hydrogen peroxide or peracetic acid. It is often used in combination with a catalytic amount of osmium tetroxide to achieve highly selective dihydroxylation of alkenes. NMO's selectivity, mild reaction conditions, and ease of handling make it a valuable reagent in organic synthesis. It is studied extensively for its synthetic applications, particularly in the development of new and efficient methods for the synthesis of pharmaceuticals and other fine chemicals.'

N-methylmorpholine N-oxide : A morpholine N-oxide resulting from the oxidation of the amino group of N-methylmorpholine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID82029
CHEMBL ID3184330
CHEBI ID52093
SCHEMBL ID1845
MeSH IDM0186106

Synonyms (103)

Synonym
n-methyl morpholine n-oxide
arc64pkj0f ,
ec 231-391-8
unii-arc64pkj0f
4-methylmorpholine 4-oxide, monohydrate
morpholine, 4-oxide
NCIOPEN2_000960
NCIOPEN2_000398
nsc-73198
7529-22-8
n-methylmorpholine oxide
nsc82153
nsc-82153
nsc73198
4-methylmorpholine 4-oxide
4-methyl-1,4.lambda.~5~-oxazinan-4-ol
morpholine, 4-methyl-, 4-oxide
4-methyl-4-oxido-morpholin-4-ium
NMO ,
4-methylmorpholine n-oxide, 97%
4-methylmorpholine-4-oxide
4-methylmorpholine n-oxide
einecs 231-391-8
nsc 73198
methyl morpholine oxide
nsc 82153
CHEBI:52093 ,
n-methylmorpholine n-oxide
n-methylmorpholine 4-oxide
C1367
4-methyl-4-oxidomorpholin-4-ium
n-methylmorpholine-n-oxide
inchi=1/c5h11no2/c1-6(7)2-4-8-5-3-6/h2-5h2,1h3
lftlokwagjyhhr-uhfffaoysa-
M0981
4-methyl-4-oxidanidyl-morpholin-4-ium
A840005
NCGC00248649-01
AKOS009159059
4-methyl morpholine n-oxide
dtxsid3029287 ,
NCGC00258033-01
cas-7529-22-8
tox21_200479
dtxcid509287
4-methylmorpholine oxide
nmmo
n-methylmorpholine n-oxide [mi]
methyl morpholine oxide [inci]
BP-30197
SCHEMBL1845
4-methyl morpholine-n-oxide
n-methylmopholine n-oxide
4-methylmorpholin-n-oxide
n-methylmorpholin-n-oxid
4-methylmorpholine-n- oxide
4-methyl-morpholine n-oxide
4methylmorpholine-n-oxide
n-methyl morpholin-n-oxide
methylmorpholine n-oxide
n-methymorpholine n-oxide
n-methyl-morpholine-n-oxide
4-methylmorpholine n oxide
4-methy-morpholine-n-oxide
4-methyl morpholine oxide
4-methylmorpholin-4-ium-4-olate
4-methyl morpholin n-oxide
n-methyimorpholine n-oxide
4-methylmorpholine-oxide
methylmorpholine-n-oxide
4-methyl-morpholine-4-oxide
4-methylmorpholine-n-oxide
4-methylmorpholine-n oxide
n-methyl-morpholine n-oxide
n-methylmorpholineoxide
n-methyl morpholine oxide
4-methyl-morpholine 4-oxide
n-methylmorphline n-oxide
4-methyl-morpholine-n-oxide
n-methyl morpholine-n-oxide
4-methyl morpholine-4-oxide
4methylmorpholine n-oxide
4-methylmopholine n-oxide
n-methyl morpholine-oxide
n-methyl-morpholine oxide
4-methyl-morpholine-n- oxide
4-methylnnorpholine n-oxide
4methylmorpholine-n oxide
4-methylmorpholin-4-oxide
4-methymorpholine n-oxide
n-methylmorpholin-n-oxide
W-104395
CHEMBL3184330
M2192
mfcd00005947
Q416248
Z381542114
EN300-37514
CS-0016218
D71257
4-methylmorpholine4-oxide
4-methylmorpholine n-oxide (50% in water, ca. 4.8mol/l)
PD055432
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
morpholine N-oxide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.76630.000214.376460.0339AID720692
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (9.30)18.2507
2000's8 (18.60)29.6817
2010's30 (69.77)24.3611
2020's1 (2.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.93 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index81.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (97.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]